Skin cancer is the most common cancer in the U.S., with risks influenced by factors like sun exposure, skin type, and income.

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

Metformin is a medication prescribed to help manage type 2 diabetes. Recent research suggests, however, this medication may potentially decrease risk of certain types of skin cancer.

Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma ...

The risk for skin cancer (any type except basal cell carcinoma) was 1.62 times higher among tattooed individuals in the case-control study.

(RTTNews) - Medicus Pharma Ltd. (MDCX) Thursday announced positive results from the interim analysis of Phase 2 study of SKNJCT-003 to non-invasively treat basal cell carcinoma of the skin (BCC).

It can be alarming to see a new spot appear on your skin, especially if it's rapidly growing. Here's what experts need you to know.

USA-based Medicus Pharma has announced a positive-trending interim analysis for the SKNJCT-003 Phase II study, which aims to treat non-invasively basal cell carcinoma of the skin (BCC).

Upon discovering a new mass grave at Al-Shifa Hospital, Gaza’s civil defense reported that it had exhumed 48 bodies on ...

Skin cancers come in all shapes and sizes, but when it comes to identifying Basal cell carcinoma, squamous cell carcinoma and melanoma, here are a few key signs to look out for: Did you read?

Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma cases and tens of thousands of melanomas diagnosed annually. Furthermore, ...

A retrospective case-control study published in the Journal of Drugs in Dermatology explored whether metformin could reduce the risk of non-melanoma skin cancers, specifically basal cell carcinoma ...